AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill DeMarco who wrote (467)	6/22/2003 7:18:24 AM
From: rrufff	of 513

Some more info on AVAN and the broad range of their possibilities. This type of company is always a gamble but if they hit on any of these, the company would justify a market cap many times its current developmental stage value. The CEO and the company is starting to get lots of recognition both for the tech and in the small cap newsletter world. avantimmune.com avantimmune.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next